You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

SARS-CoV-2 Test Information

Four Core Actions to Fight Infections & Antimicrobial Resistance

1

Preventing the Spread

2

Tracking Resistant Bacteria

3

Improving Antibiotic Prescribing and Stewardship

4

Developing Advanced Diagnostics & New Antibiotics

Impact of Rapid Diagnostics

Shortened hospital length of stay by 2.5 days3

Decreased lethal bloodstream infections in patients by 36%3

Reduced time to effective therapy by 5 hours3

Related Product Links

Connect To Better Outcomes

Request Info

1.Casari E, et al. Reducing rates of Clostridium difficile infection by switching to a stand-alone NAAT with clear sampling criteria. Antimicrob Resist Infect Control. 2018;7:40.

2.Birgand G, et al. Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrob Resist Infect Control. 2013 Nov 4;2(1):30.

3.Wenzler E, Using rapid diagnostics to fight resistance. Infectious Disease Special Edition. May 30, 2018. https://www.idse.net/Resistance--Stewardship/Article/09-15/Using-Rapid-
Diagnostics-to-Fight-Resistance/48730. Accessed 12 July 2018

4.Bauer KA, et al. An Antimicrobial Stewardship Program’s Impact with Rapid olymerase chain reaction methicillin-resistant/ Staphylococcus Blood Culture Test in Patients with Staphylococcus Bacteremia. ClinInfect Dis. 2010; 51(9):1074–1080.

5.Humphreys H, et al. Staphylococcus and surgical site infections: benefits of screening and decolonization before surgery. J Hosp Infect. 2016. Nov;94(3):295-304.

6.Rudd K, et al. Molecular Diagnostics Can Lead To Early Optimization of Antimicrobial Therapy for Staphylococcal Bacteremia: Experience at a Large Tertiary-Care VA Medical Center. Open Forum Infectious Diseases, Volume 3, Issue suppl_1, 1 December 2016, 1863. Accessed 12 July 2018.

Back to Top